Infection, 2025 Antigen-specific chemokine CCL3 as a biomarker for distinguishing between recent and remote tuberculosis infection Chang C., Ma Z., Ren W. et al. Olink Target 96Infectious DiseasesPatient StratificationPlasma | | | | |
Journal of Inflammation Research, 2025 Using Olink Proteomics to Identify Inflammatory Biomarkers in the Cerebrospinal Fluid in Guillain-Barré Syndrome Sun S., Li M., Song J. et al. Olink Target 96NeurologyPatient StratificationCSF | | | | |
Molecular Oncology, 2025 Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer Gudoityte G., Sharma O., Leuenberger L. et al. Olink Target 96OncologyPathophysiologyCell Culture Supernatant | | | | |
International Journal of Cardiology Cardiovascular Risk and Prevention, 2025 Circulating protein biomarkers and their association with vulnerable plaque characteristics – a PROSPECT II substudy Sharma T., Maehara A., Maeng M. et al. Olink Target 96CVDPatient StratificationPlasma | | | | |
Journal of Cardiac Failure, 2025 The Association between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures measured by Invasive Hemodynamic Monitoring de Jong M., Allach Y., Kamar S. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Med, 2025 Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis uncovers pathways associated with mortality Le T., van Abeelen K., Ardiansyah E. et al. Olink Target 96Infectious DiseasesPathophysiologyCSF | | | | |
Nature Communications, 2025 The health impacts and genetic architecture of food liking in cardio-metabolic diseases Jiang W., Wang H., Geng Y. et al. Olink Explore 3072/384CVDNutritional SciencePathophysiologyPlasma | | | | |
Signal Transduction and Targeted Therapy, 2025 Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study Xie M., Bao M., Dong X. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationPlasma | | | | |
European Neuropsychopharmacology, 2025 Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis Oliva V., Possidente C., Fanelli G. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Nature Communications, 2025 FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma Beffinger M., Schellhammer L., Taskoparan B. et al. Olink Target 96OncologyPathophysiologyTissue Culture Conditioned Medium | | | | |
Circulation, 2025 Proteomic Signatures for Risk Prediction of Atrial Fibrillation Park H., Norby F., Kim D. et al. Olink Explore 3072/384CVDPatient StratificationPlasma | | | | |
The American Journal of Clinical Nutrition, 2025 Relationship of healthy lifestyle with healthy aging and the mediation by plasma proteins: a prospective cohort study Fang F., Liu Z., Lyu J. et al. Olink Explore 3072/384AgingPathophysiologyPlasma | | | | |
Medicine, 2025 Roles of plasma proteins in mediating the causal effect of the lipid species on gastric cancer: Insights from proteomic and two-step Mendelian randomization Dong Z., Chen Z., Yu K. et al. Olink Explore 3072/384OncologyCross-platform ValidationPlasma | | | | |
Journal of Interferon & Cytokine Research, 2025 Significant Associations Between Blood Cell Counts and a Large Number of Salivary Cytokines, Chemokines, and Growth Factors Eriksson L., Eriksson M., Gordh T. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySaliva | | | | |
Nature Communications, 2025 In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome Mizumaki H., Gao S., Wu Z. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Immunology Letters, 2025 Dynactin subunit 1 facilitates mast cell degranulation to drive food allergy pathogenesis Zhao M., Zhang H., Liu Z. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyMouse Gut Lavage Fluid | | | | |
Blood Journal, 2025 Ruxolitinib Targets JAK-STAT Signaling to Modulate Neutrophil Activation in Refractory Macrophage Activation Syndrome Ma Y., Chen X., Wang M. et al. Olink Target 96HematologyPathophysiologyPlasma | | | | |
Allergy, 2025 Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins Fehr D., Huynh‐Tran V., Maintz L. et al. Olink Target 96CVDDermatological DiseasesPathophysiologySerum | | | | |
Brain and Behavior, 2025 Causal Relationships Between the Gut Microbiota, Inflammatory Cytokines, and Amyotrophic Lateral Sclerosis: A Mendelian Randomization Analysis Changqing L., Leying Y., Caiyun M. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Discover Oncology, 2025 Exploring the causal relationship between immune factors and chondrosarcoma: a Mendelian randomization study Xu T., Xiao W., Li W. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |